Evidence map›Paper›PMID 36903254›Full record

ReviewMolecules (Basel, Switzerland)2023

Recent Developments in Chemical Derivatization of Microcrystalline Cellulose (MCC): Pre-Treatments, Functionalization, and Applications.

Gabriele Lupidi, Genny Pastore, Enrico Marcantoni, Serena Gabrielli

Full text readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Cellulose-Based Electrochemical Sensors.Sensors (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gabriele LupidiChemistry Division, School of Science and Technology, Università Degli Studi di Camerino, ChIP Building, Via Madonna delle Carceri, 62032 Camerino, Italy.ORCID 0000-0001-9891-0552
Genny PastoreChemistry Division, School of Science and Technology, Università Degli Studi di Camerino, ChIP Building, Via Madonna delle Carceri, 62032 Camerino, Italy.
Enrico MarcantoniChemistry Division, School of Science and Technology, Università Degli Studi di Camerino, ChIP Building, Via Madonna delle Carceri, 62032 Camerino, Italy.ORCID 0000-0002-8686-3987
Serena GabrielliChemistry Division, School of Science and Technology, Università Degli Studi di Camerino, ChIP Building, Via Madonna delle Carceri, 62032 Camerino, Italy.ORCID 0000-0002-2048-5813

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microcrystalline Cellulose (MCC) is an isolated, colloidal crystalline portion of cellulose fibers, and it is a valuable alternative to non-renewable fossil-based materials. It is used for a large plethora of different fields, such as composites, food applications, pharmaceutical and medical developments, and cosmetic and material industries. The interest of MCC has also been driven by its economic value. In the last decade, particular attention has been driven to the functionalization of its hydroxyl groups to expand the field of applications of such biopolymer. Herein, we report and describe several pre-treatment methods that have been developed to increase the accessibility of MCC by breaking its dense structure allowing further functionalization. This review also collects the results that have appeared in the literature during the last two decades on the utilization of functionalized MCC as adsorbents (dyes, heavy metals, and carbon dioxide), flame retardants, reinforcing agents, energetic materials, such as azide- and azidodeoxy-modified, and nitrate-based cellulose and biomedical applications.

Indexed as

applicationsfunctionalizationmicrocrystalline cellulosepre-treatments

Identifiers

PMID36903254
PMCPMC10004355

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read24
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.